The United States Point-Of-Care Devices Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031.
United States Point-Of-Care Devices Market By Application
- Glucose Monitoring
- Infectious Disease Testing
- Cardiac Markers Testing
- Coagulation Monitoring
- Pregnancy & Fertility Testing
The United States point-of-care devices market is segmented by application into several key areas. Glucose monitoring devices constitute a significant segment, driven by the rising prevalence of diabetes and the demand for continuous monitoring solutions. Infectious disease testing is another crucial application area, supported by the need for rapid and accurate diagnosis in healthcare settings to enable timely treatment and infection control measures.
Cardiac markers testing devices are essential for the detection of heart-related conditions at the point of care, aiding in early diagnosis and management. Coagulation monitoring devices play a critical role in assessing clotting factors quickly, particularly beneficial in emergency departments and critical care settings. Additionally, pregnancy and fertility testing devices cater to the growing demand for convenient, rapid tests that can be performed outside traditional laboratory environments.